YURAK-QON TOMIR KASALLIKLARI: ETIOLOGIYASI, PATOGENEZI, DIAGNOSTIKASI VA DAVOLASH USULLARI
Keywords:
yurak-qon tomir kasalliklari, ateroskleroz, miokard infarkti, gipertoniya.Abstract
Ushbu maqolada yurak-qon tomir kasalliklari (YQTK) zamonaviy tibbiy nuqtai nazardan keng ko'lamda tahlil etiladi. Maqolada kasalliklarning rivojlanish sabablari (etiologiya), organizmdagi patologik o'zgarishlar mexanizmi (patogenez), klinik belgilari, zamonaviy diagnostika usullari hamda davolash va profilaktika tadbirlari ilmiy asosda yoritilgan. Jahon sog'liqni saqlash tashkiloti (JSST) ma'lumotlariga ko'ra, yurak-qon tomir kasalliklari insoniyat o'rtasidagi o'lim sabablarining birinchi o'rinda turishi bu sohada kompleks tibbiy yondashuvni zarur qiladi. Maqolada klinik amaliyotda qo'llaniladigan zamonaviy uslublar, dori-darmon terapiyasi va jarrohlik muolajalarining samaradorligi haqida batafsil ma'lumot berilgan
References
World Health Organization. (2023). Cardiovascular diseases (CVDs) – Fact sheet. Geneva: WHO Press.
Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473(7347), 317–325.
Yancy, C. W., et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure. Journal of the American College of Cardiology, 62(16), e147–e239.
O'zbekiston Respublikasi Sog'liqni saqlash vazirligi. (2022). Kardiovaskulyar kasalliklarning oldini olish va davolash bo'yicha milliy klinik qo'llanma. Toshkent.
Mancia, G., et al. (2023). 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension, 41(12), 1874–2071.
Visseren, F. L. J., et al. (2021). 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal, 42(34), 3227–3337.
Knuuti, J., et al. (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477.
Collet, J. P., et al. (2021). 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42(14), 1289–1367.
Downloads
Published
Issue
Section
How to Cite
